WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2023> 26> 4

Volume: 26 Issue: 4

1. Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells 
via ROS/Sirt3/SOD2 Pathway. Page:245—256
2. A Real-world Study on the Incidence and Outcome of Immune-related Adverse Events in Lung Cancer Patients. Page:257—264
3. Growth Regularity of Pulmonary Ground Glass Nodules Based on 3D Reconstruction Technology. Page:265—273
4. Prognosis Analysis of Early-stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy. Page:274—280
5. Early Onset Pulmonary Events and Management Strategies during the Treatment of 
ALK Positive NSCLC Patients with Brigatinib. Page:281—290
6. Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer. Page:291—302
7. Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of 
Small Cell Lung Cancer. Page:303—309
8. Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer. Page:310—318
9. Ceritinib as First-line Treatment for Advanced Lung Adenocarcinoma 
with COX7A2L-ALK Fusion: A Case Report and Literature Review. Page:319—324
10. Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression. Page:309—309

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.